Keresty Georgia
SEC insider (Form 3/4/5 filer). CIK 0001773532. Director at Solid Biosciences Inc. (SLDB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in CAMBRIDGE, MA.
Companies Keresty Georgia has filed insider reports for
- Solid Biosciences Inc. (SLDB): Director
- Intellia Therapeutics, Inc. (NTLA): Director
Keresty Georgia
CIK: 0001773532
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Jun 9, 2026NTLA
Intellia Therapeutics, Inc.
AwardDirect9.2K shares- - Jun 12, 2025SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Jun 11, 2025NTLA
Intellia Therapeutics, Inc.
AwardDirect8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Jun 9, 2026 |  NTLA Intellia Therapeutics, Inc. | Award | 9,200 | - | $0 | Direct |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | Award | 8,000 | - | - | Direct |
1-4 of 4 transactions